Parkinson's Disease Trial, Recruiting (NCT06090682)

Parkinson's Disease Trial, Recruiting NCT06090682 Sponsor: Tianjin Huanhu Hospital Condition: Parkinson's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06090682 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Parkinsons Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with Parkinson's disease according to a specific set of widely used medical guidelines (called the UK Parkinson's Disease Society Brain Bank criteria)
People who have had Parkinson's disease for more than 5 years
People whose motor symptoms improve by 30% or more when taking levodopa (a common Parkinson's medication)
People for whom a type of brain surgery called deep brain stimulation of the subthalamic nucleus (STN-DBS) has been recommended by their doctors

Who may not be able to join:

People with severe problems with thinking, memory, or cognitive function
People with serious mental health conditions
People whose motor symptoms improve by less than 30% when taking levodopa
People with a Parkinson's-like condition that is not standard Parkinson's disease (sometimes called atypical parkinsonism)
People who have medical reasons that make surgery unsafe or unsuitable for them (confirm with trial site for specific details)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86 18956405513

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06090682

Sponsor: Tianjin Huanhu Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Parkinson's Disease

Trial contact: +86 18956405513

More information: https://clinicaltrials.gov/study/NCT06090682

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with Parkinson's disease according to a specific set of widely used medical guidelines (called the UK Parkinson's Disease Society Brain Bank criteria)
People who have had Parkinson's disease for more than 5 years
People whose motor symptoms improve by 30% or more when taking levodopa (a common Parkinson's medication)
People for whom a type of brain surgery called deep brain stimulation of the subthalamic nucleus (STN-DBS) has been recommended by their doctors

Who may not be able to join:

People with severe problems with thinking, memory, or cognitive function
People with serious mental health conditions
People whose motor symptoms improve by less than 30% when taking levodopa
People with a Parkinson's-like condition that is not standard Parkinson's disease (sometimes called atypical parkinsonism)
People who have medical reasons that make surgery unsafe or unsuitable for them (confirm with trial site for specific details)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Tianjin Huanhu Hospital

Registry

ClinicalTrials.gov

Start date

1 November 2023

Est. completion

1 November 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Montreal Cognitive Rating Scale(MoCA); verbal fluency test (VF)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov